← Back to Clinical Trials
Recruiting NCT06196307

NCT06196307 Early Warning and Classification Model for Acute Non-traumatic Chest Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06196307
Status Recruiting
Phase
Sponsor Xiao-nan He
Condition Chest Pain
Study Type OBSERVATIONAL
Enrollment 10,000 participants
Start Date 2022-08-30
Primary Completion 2027-12-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Clinical evaluation, laboratory and cardiac imaging results, medication, surgery, and any hospitalization

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 10,000 participants in total. It began in 2022-08-30 with a primary completion date of 2027-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Acute non-traumatic chest pain is one of the common causes of presentation in emergency patients, but the causes of acute non-traumatic chest pain are complex, the severity of the condition varies greatly, and the specificity of symptoms is not high. Machine learning and intelligent auxiliary models can greatly shorten the time of clinical decision-making, and improve the accuracy of etiological diagnosis in patients with chest pain, reduce the rate of misdiagnosis and missed diagnosis, and provide a clear direction for further treatment.

Eligibility Criteria

Inclusion Criteria: 1. Age ≥ 18 years 2. Symptom onset or worsening within 24 hours before presentation, with a chief complaint of acute chest pain meeting the broad definition of chest pain (2021 AHA) 3. Presentation to the emergency department, with a clinical diagnosis consistent with non-traumatic chest pain 4. Signed informed consent Exclusion Criteria: 1. traumatic chest pain 2. systemic pain caused by malignant tumors or rheumatic diseases involving the chest 3. Patients were lost to follow-up

Contact & Investigator

Central Contact

Xiaonan / He, Professor

✉ hxndoctor@126.com

📞 15001108399

Frequently Asked Questions

Who can join the NCT06196307 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Chest Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06196307 currently recruiting?

Yes, NCT06196307 is actively recruiting participants. Contact the research team at hxndoctor@126.com for enrollment information.

Where is the NCT06196307 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06196307 clinical trial?

NCT06196307 is sponsored by Xiao-nan He. The trial plans to enroll 10,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology